microrna
mirna
extens
famili
small
regulatori
rna
function
bind
complementari
mrna
primarili
untransl
region
inhibit
express
reduc
mrna
translat
andor
stabil
mirna
initi
transcrib
long
primirna
sequenti
process
rnase
iii
enzym
drosha
nucleu
dicer
cytoplasm
gener
matur
mirna
load
rna
induc
silenc
complex
risc
consist
minim
one
four
mammalian
argonaut
protein
well
member
protein
famili
mirna
function
guid
rna
target
risc
complementari
mrna
sequenc
specif
mrna
analysi
reveal
complementar
nucleotid
mirna
socal
seed
region
particularli
import
effect
risc
recruit
although
noncanon
site
incomplet
seed
complementar
also
report
importantli
risc
recruit
target
site
occlud
rna
secondari
structur
bound
protein
ineffici
upon
infect
cell
virus
encount
wide
rang
mirna
speci
gener
differ
mirna
per
cell
mirna
vari
greatli
tissu
exampl
express
high
level
hepatocyt
absent
almost
cell
primarili
express
muscl
tissu
neuron
cell
inde
mani
known
human
mirna
speci
show
tissuespecif
express
pattern
mean
virus
infect
multipl
cell
type
need
way
avoid
inhibit
wide
rang
mirna
distinct
mrnatarget
specif
analys
interact
virus
cellular
mirna
reveal
virus
influenc
cellular
mirna
biogenesi
effector
mechan
sever
differ
way
virus
clearli
benefit
mirna
express
exampl
almost
herpesvirus
examin
express
substanti
number
mirna
facilit
viral
replic
andor
regul
viral
entri
exit
latenc
dna
virus
also
express
mirna
includ
adeno
polyoma
virus
mirna
detect
rna
virus
examin
far
except
retroviru
bovin
leukemia
viru
blv
transcrib
short
pol
iiidriven
mirna
precursor
integr
blv
provirus
virus
also
benefit
cellular
mirna
speci
clearest
exampl
hepat
c
viru
hcv
requir
replic
moreov
sever
virus
report
induc
specif
cellular
mirna
demonstr
instanc
induct
facilit
viral
replic
cultur
appar
downregul
specif
cellular
mrna
target
antivir
potenti
certain
virus
clearli
benefit
cellular
mirna
unclear
virus
avoid
inhibit
viral
mrna
function
cellular
mirna
inde
sever
report
demonstr
inhibit
virus
cellular
mirna
publish
howev
especi
given
cellular
mirna
highli
conserv
evolut
seem
unlik
virus
would
fail
evolv
mechan
prevent
cellular
mirnamedi
inhibit
normal
target
tissu
might
howev
current
unclear
sever
possibl
mechan
propos
rel
littl
known
secondari
structur
viral
rna
although
data
suggest
high
level
secondari
structur
common
featur
one
viral
rna
examin
detail
rna
genom
also
function
mrna
viral
gag
gagpol
protein
rna
shown
fold
extens
secondari
structur
rel
area
unfold
henc
presum
avail
risc
bind
predict
valid
comprehens
analysi
suscept
genom
small
interf
rna
sirna
mammalian
cell
function
indistinguish
mirna
research
gener
sirna
specif
genom
slide
sirna
target
along
viral
genom
onenucleotid
increment
rel
sirna
found
inhibit
replic
gene
express
effect
predict
bind
region
viral
rna
genom
use
biochem
approach
predict
adopt
open
unfold
conform
recent
abil
genom
bind
endogen
cellular
mirna
relev
target
cell
cell
nonphysiolog
target
cell
hela
cell
examin
use
technolog
call
photoactivat
ribonucleosideenhanc
crosslink
immunoprecipit
parclip
parclip
techniqu
involv
puls
cell
highli
photoactivat
uridin
analog
crosslink
endogen
rna
bound
protein
irradi
nm
crosslink
protein
bound
rna
recov
immunoprecipit
risc
use
monoclon
antibodi
bind
site
footprint
rnase
treatment
risc
bind
site
comprehens
identifi
deep
sequenc
small
rna
gener
sequenc
cluster
align
endogen
mirna
speci
analysi
risc
bind
genom
inde
identifi
sever
bind
site
occupi
risc
program
endogen
cellular
mirna
could
shown
indic
assay
confer
modest
repress
mrna
function
howev
perhap
interest
find
viral
mrna
despit
contribut
total
mrna
transcriptom
infect
cell
fact
gave
rise
approxim
assign
risc
bind
site
remain
approxim
contribut
cellular
mrna
viral
mrna
minimum
less
like
bind
risc
cellular
mrna
consist
idea
mrna
least
evolv
global
avoid
cellular
mirna
adopt
rna
secondari
structur
preclud
risc
bind
complet
understand
interact
virus
cellular
mirna
must
await
detail
dissect
effect
endogen
mirna
wide
rang
viral
speci
current
data
suggest
virus
like
evolv
number
strategi
avoid
inhibit
ubiquit
cellular
regulatori
rna
whether
perturb
avoid
strategi
potenti
lead
develop
reagent
use
diseas
prevent
novel
form
attenu
viral
vaccin
remain
determin
